These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35047421)

  • 41. Augmentation of Urinary Lactoferrin Enhances Host Innate Immune Clearance of Uropathogenic Escherichia coli.
    Patras KA; Ha AD; Rooholfada E; Olson J; Ramachandra Rao SP; Lin AE; Nizet V
    J Innate Immun; 2019; 11(6):481-495. PubMed ID: 31055580
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Uropathogenic Escherichia coli induces serum amyloid a in mice following urinary tract and systemic inoculation.
    Erman A; Lakota K; Mrak-Poljsak K; Blango MG; Krizan-Hergouth V; Mulvey MA; Sodin-Semrl S; Veranic P
    PLoS One; 2012; 7(3):e32933. PubMed ID: 22427910
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rapid Bladder Interleukin-10 Synthesis in Response to Uropathogenic Escherichia coli Is Part of a Defense Strategy Triggered by the Major Bacterial Flagellar Filament FliC and Contingent on TLR5.
    Acharya D; Sullivan MJ; Duell BL; Goh KGK; Katupitiya L; Gosling D; Chamoun MN; Kakkanat A; Chattopadhyay D; Crowley M; Crossman DK; Schembri MA; Ulett GC
    mSphere; 2019 Nov; 4(6):. PubMed ID: 31776239
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biofilm formation by uropathogenic Escherichia coli: a complicating factor for treatment and recurrence of urinary tract infections.
    Naziri Z; Kilegolan JA; Moezzi MS; Derakhshandeh A
    J Hosp Infect; 2021 Nov; 117():9-16. PubMed ID: 34428502
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of flavohemoglobin in combating nitrosative stress in uropathogenic Escherichia coli--implications for urinary tract infection.
    Svensson L; Poljakovic M; Säve S; Gilberthorpe N; Schön T; Strid S; Corker H; Poole RK; Persson K
    Microb Pathog; 2010 Sep; 49(3):59-66. PubMed ID: 20399845
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Virulence factors of uropathogenic Escherichia coli of urinary tract infections and asymptomatic bacteriuria in children.
    Yun KW; Kim HY; Park HK; Kim W; Lim IS
    J Microbiol Immunol Infect; 2014 Dec; 47(6):455-61. PubMed ID: 24064288
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Peptidoglycan Sensing Prevents Quiescence and Promotes Quorum-Independent Colony Growth of Uropathogenic Escherichia coli.
    DiBiasio EC; Ranson HJ; Johnson JR; Rowley DC; Cohen PS; Camberg JL
    J Bacteriol; 2020 Sep; 202(20):. PubMed ID: 32778561
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A high-throughput assay for the measurement of uropathogenic Escherichia coli attachment to urinary bladder cells.
    García Méndez KB; Bragagnolo G; O'Callaghan D; Lavigne JP; Keriel A
    Int J Exp Pathol; 2016 Apr; 97(2):194-201. PubMed ID: 27273601
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Single clinical isolates from acute uncomplicated urinary tract infections are representative of dominant in situ populations.
    Willner D; Low S; Steen JA; George N; Nimmo GR; Schembri MA; Hugenholtz P
    mBio; 2014 Feb; 5(2):e01064-13. PubMed ID: 24570371
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of fluoroquinolone-resistant and broad-spectrum cephalosporin-resistant community-acquired urinary tract infections in Rio de Janeiro: Impact of Escherichia coli genotypes ST69 and ST131.
    de Souza da-Silva AP; de Sousa VS; de Araújo Longo LG; Caldera S; Baltazar ICL; Bonelli RR; Santoro-Lopes G; Riley LW; Moreira BM
    Infect Genet Evol; 2020 Nov; 85():104452. PubMed ID: 32634601
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genomic diversity and fitness of E. coli strains recovered from the intestinal and urinary tracts of women with recurrent urinary tract infection.
    Chen SL; Wu M; Henderson JP; Hooton TM; Hibbing ME; Hultgren SJ; Gordon JI
    Sci Transl Med; 2013 May; 5(184):184ra60. PubMed ID: 23658245
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A systematic review and meta-analysis of antibiotic resistance patterns, and the correlation between biofilm formation with virulence factors in uropathogenic E. coli isolated from urinary tract infections.
    Zhao F; Yang H; Bi D; Khaledi A; Qiao M
    Microb Pathog; 2020 Jul; 144():104196. PubMed ID: 32283258
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Surface display of uropathogenic Escherichia coli FimH in Lactococcus lactis: In vitro characterization of recombinant bacteria and its protectivity in animal model.
    Derakhshandeh S; Shahrokhi N; Khalaj V; Habibi M; Moazzezy N; Asadi Karam MR; Bouzari S
    Microb Pathog; 2020 Apr; 141():103974. PubMed ID: 31926238
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urine Cytokine and Chemokine Levels Predict Urinary Tract Infection Severity Independent of Uropathogen, Urine Bacterial Burden, Host Genetics, and Host Age.
    Armbruster CE; Smith SN; Mody L; Mobley HLT
    Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29891542
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infection.
    Nagamatsu K; Hannan TJ; Guest RL; Kostakioti M; Hadjifrangiskou M; Binkley J; Dodson K; Raivio TL; Hultgren SJ
    Proc Natl Acad Sci U S A; 2015 Feb; 112(8):E871-80. PubMed ID: 25675528
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Escherichia coli B2 Phylogenetic Subgroups in the Infant Gut Microbiota: Predominance of Uropathogenic Lineages in Swedish Infants and Enteropathogenic Lineages in Pakistani Infants.
    Nowrouzian FL; Clermont O; Edin M; Östblom A; Denamur E; Wold AE; Adlerberth I
    Appl Environ Microbiol; 2019 Dec; 85(24):. PubMed ID: 31562173
    [No Abstract]   [Full Text] [Related]  

  • 57. Metabolism mechanism of glycosaminoglycans by the gut microbiota: Bacteroides and lactic acid bacteria: A review.
    Dong J; Cui Y; Qu X
    Carbohydr Polym; 2024 May; 332():121905. PubMed ID: 38431412
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Indwelling Urinary Catheter Model of Proteus mirabilis Infection.
    Smith SN; Armbruster CE
    Methods Mol Biol; 2019; 2021():187-200. PubMed ID: 31309506
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Urinary tract infection: Pathogenicity, antibiotic resistance and development of effective vaccines against Uropathogenic Escherichia coli.
    Asadi Karam MR; Habibi M; Bouzari S
    Mol Immunol; 2019 Apr; 108():56-67. PubMed ID: 30784763
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Presence of putative repeat-in-toxin gene tosA in Escherichia coli predicts successful colonization of the urinary tract.
    Vigil PD; Stapleton AE; Johnson JR; Hooton TM; Hodges AP; He Y; Mobley HL
    mBio; 2011; 2(3):e00066-11. PubMed ID: 21540363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.